Nav: Home

Improved airway-targeted gene delivery in a pig model of cystic fibrosis

September 08, 2016

Cystic fibrosis (CF) is characterized by accumulation of thick mucus in the lungs and is associated with a high incidence of bacterial infection. Mutations in the gene encoding CF transmembrane conductance regulator (CFTR) underlie the disease. Gene therapy to deliver a normal copy of the CFTR gene has shown promise in both pre-clinical models and clinical trials; however, current gene delivery methods are inefficient and do not result in sustained expression of functional CFTR in the airways. Two studies in this issue of JCI Insight report the development and use of viral vector-based delivery of CFTR in pig models of CF. A team led by Patrick Sinn and Paul McCray Jr. of the University of Iowa developed a lentiviral-based vector that was delivered through the nose to newborn CF pigs. Analysis of these animals revealed evidence of functional CFTR expression in the airways. A second team led by Joseph Zabner of the University of Iowa and David Schaffer of the University of California, Berkeley, generated an adeno-associated virus (AAV) that homes to the pig airway to mediate expression of functional CFTR in the airways of 1 week-old CF pigs. Together, these reports indicate that viral vector-based approaches could potentially improve the effectiveness of CFTR gene therapy.

TITLE:

Lentiviral-mediated phenotypic correction of cystic fibrosis pigs

AUTHOR CONTACT:

Paul B. McCray, Jr.
The University of Iowa
Email: paul-mccray@uiowa.edu

Patrick L. Sinn
The University of Iowa
Email: patrick-sinn@uiowa.edu.

View this article at:http://insight.jci.org/articles/view/88730?key=b4689e6b7aedc95452bc

TITLE:

CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes

AUTHOR CONTACT:

Joseph Zabner
University of Iowa Carver College of Medicine
Email:joseph-zabner@uiowa.edu

David Schaffer
University of California, Berkeley
Email: schaffer@berkeley.edu.

View this article at: http://insight.jci.org/articles/view/88728?key=7e8c808d25cd5e3b5597
-end-
JCI Insight is the newest publication from the American Society of Clinical Investigation, a nonprofit honor organization of physician-scientists. JCI Insight is dedicated to publishing a range of translational biomedical research with an emphasis on rigorous experimental methods and data reporting. All articles published in JCI Insight are freely available at the time of publication. For more information about JCI Insight and all of the latest articles go to http://www.insight.jci.org.

JCI Journals

Related Gene Therapy Articles:

Gene therapy/gene editing combo could offer hope for some genetic disorders
A hybrid approach that combines elements of gene therapy with gene editing converted an experimental model of a rare genetic disease into a milder form, significantly enhancing survival, shows a multi-institutional study led by the University of Pennsylvania and Children's National Hospital in Washington, D.C.
Using gene therapy to treat chronic traumatic encephalopathy
A new study shows the feasibility of using gene therapy to treat the progressive neurodegenerative disorder chronic traumatic encephalopathy (CTE).
New technology allows control of gene therapy doses
Scientists at Scripps Research in Jupiter have developed a special molecular switch that could be embedded into gene therapies to allow doctors to control dosing.
Gene therapy: Development of new DNA transporters
Scientists at the Institute of Pharmacy at Martin Luther University Halle-Wittenberg (MLU) have developed new delivery vehicles for future gene therapies.
Non-viral gene therapy to speed up cancer research
A new treatment method promises to speed up gene therapy research and could bring new, patient friendly cancer treatments to market faster.
Gene therapy promotes nerve regeneration
Researchers from the Netherlands Institute for Neuroscience and the Leiden University Medical Center have shown that treatment using gene therapy leads to a faster recovery after nerve damage.
Gene therapy for blood disorders
Delivering gene-regulating material to cells that live deep in our bone marrow and direct the formation of blood cells.
Realizing the potential of gene therapy for neurological disorders
Promising findings from preclinical animal studies show the potential of gene therapy for treating incurable neurological disorders.
Gene therapy vectors carrying the telomerase gene do not increase the risk of cancer
Researchers from the Spanish National Cancer Research Centre (CNIO) have shown in a new study that the gene therapy with telomerase that they have developed, and which has proven to be effective in mice against diseases caused by excessive telomere shortening and ageing, does not cause cancer or increase the risk of developing it, even in a cancer-prone setting.
Study advances gene therapy for glaucoma
In a study published today in the scientific journal Investigative Ophthalmology and Visual Science, Kaufman and Curtis Brandt, a fellow professor of ophthalmology and visual sciences at UW-Madison, showed an improved tactic for delivering new genes into the eye's fluid drain, called the trabecular meshwork.
More Gene Therapy News and Gene Therapy Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Clint Smith
The killing of George Floyd by a police officer has sparked massive protests nationwide. This hour, writer and scholar Clint Smith reflects on this moment, through conversation, letters, and poetry.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.